SynCardia Systems Nailed for MDR Deficiencies

The GMP Letter
A A
The FDA issued a warning letter to SynCardia Systems over issues regarding medical device reporting at its Tucson, Arizona facility.

To View This Article:

Login

Subscribe To The GMP Letter